Trovagene, Inc. (TROV): Bridger Management Reports 11% Stake and Goes Activist

Page 6 of 6

Page 6 of 6 – SEC Filing
EXHIBIT I
The undersigned acknowledge and agree that the foregoing statement on Schedule 13D is filed on behalf of each of the undersigned and that all subsequent amendments to such statement on Schedule 13D shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing statements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments and for the completeness and accuracy of the information concerning him or it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the other entity or person, except to the extent that he or it knows or has reason to believe that such information is inaccurate.
 Dated:  April 5, 2016
BRIDGER MANAGEMENT, LLC
By:
/s/Roberto Mignone
Name:  Roberto Mignone
Title:    Manager
 ROBERTO MIGNONE
  /s/Roberto Mignone

Follow Cardiff Oncology Inc. (NASDAQ:CRDF)

Page 6 of 6